The Greenbrier Companies, Inc. (GBX)
NYSEIndustrialsRailroadsSnapshot 2026-09-04
$43.26+1.10%
Close 2026-09-04 · 1-day change
NYSEIndustrialsRailroadsSnapshot 2026-09-04
QuarterlyIQ Insights · GBX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenues | 2,629.6 | 3,240.2 | 3,544.7 | 3,944.0 | 2,977.7 | 1,747.9 | 2,792.2 | 3,033.6 | 2,519.5 | 2,169.2 | 2,679.5 | 2,605.3 | 2,204.0 | 1,756.4 | 1,807.7 |
| Total Revenues | 2,629.6 | 3,240.2 | 3,544.7 | 3,944.0 | 2,977.7 | 1,747.9 | 2,792.2 | 3,033.6 | 2,519.5 | 2,169.2 | 2,679.5 | 2,605.3 | 2,204.0 | 1,756.4 | 1,807.7 |
| Cost of Revenues | 2,231.9 | 2,632.7 | 2,986.2 | 3,502.9 | 2,671.7 | 1,516.3 | 2,439.1 | 2,667.1 | 2,110.4 | 1,747.9 | 2,128.1 | 2,067.9 | 1,881.7 | 35.7 | 37.4 |
| Gross Profit | 397.7 | 607.5 | 558.5 | 441.1 | 306.0 | 231.6 | 353.1 | 366.5 | 409.1 | 421.3 | 551.4 | 537.4 | 322.2 | 206.4 | 214.4 |
| Operating Expenses & Income | |||||||||||||||
| Selling, General & Admin | 243.3 | 263.3 | 247.1 | 235.3 | 225.2 | 191.8 | 204.7 | 213.3 | 200.4 | 170.6 | 158.7 | 151.8 | 125.3 | 103.2 | 104.6 |
| R&D Expenses | — | 5.5 | 5.2 | 4.0 | 5.4 | 6.3 | 5.8 | 5.4 | 6.0 | 4.2 | 2.7 | 2.5 | 3.6 | 2.0 | 2.0 |
| Operating Income | 190.2 | 360.1 | 324.5 | 176.4 | 118.0 | 41.0 | 168.4 | 184.1 | 253.0 | 260.4 | 408.6 | 386.9 | 239.5 | 41.7 | 118.8 |
| Earnings from Continuing Operations | |||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.1 | 0.1 |
| Interest & Investment Income | — | — | — | — | — | — | — | 0.4 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | 0.8 | 0.3 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | (0.7) | (0.2) |
| Asset Writedown | — | — | — | — | — | — | — | 10.0 | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 127.1 | 284.4 | 223.7 | 91.0 | 60.6 | (8.6) | 124.8 | 153.2 | 223.6 | 236.2 | 395.1 | 375.7 | 220.8 | 19.5 | 94.0 |
| Income Tax Expense | 36.9 | 91.4 | 62.0 | 24.6 | 18.1 | (40.2) | 40.2 | 41.6 | 32.9 | 64.0 | 112.3 | 112.2 | 72.4 | 25.1 | 32.4 |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | — | — | — | — | 263.6 | 148.4 | (5.6) | 61.6 |
| Net Income | |||||||||||||||
| Minority Interest | 1.9 | 9.0 | 12.6 | 13.1 | 6.9 | 2.7 | 38.6 | 34.7 | 20.3 | 44.4 | 101.6 | 72.5 | 37.9 | 5.7 | 2.5 |
| Net Income | 107.1 | 204.1 | 160.1 | 62.5 | 46.9 | 32.4 | 49.0 | 71.1 | 151.8 | 116.1 | 183.2 | 192.8 | 111.9 | (11.0) | 58.7 |
| Per Share | |||||||||||||||
| Basic EPS | 3.46 | 6.55 | 5.15 | 1.95 | 1.44 | 0.99 | 1.50 | 2.18 | 4.92 | 3.97 | 6.28 | 6.85 | 3.97 | (0.41) | 2.21 |
| Diluted EPS | 3.37 | 6.35 | 4.96 | 1.89 | 1.40 | 0.96 | 1.46 | 2.14 | 4.68 | 3.65 | 5.73 | 5.93 | 3.44 | (0.41) | 1.91 |
| Revenue per Share | 82.84 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | — | — | — | — | 1.00 | 0.96 | 0.86 | 0.81 | 0.60 | 0.15 | — | — |
| Basic Weighted Avg Shares | 30.9 | 31.2 | 31.1 | 32.0 | 32.6 | 32.6 | 32.7 | 32.6 | 30.9 | 29.2 | 29.2 | 28.2 | 28.2 | 26.7 | 26.6 |
| Diluted Weighted Avg Shares | 31.7 | 32.1 | 32.4 | 33.8 | 33.6 | 33.7 | 33.4 | 33.2 | 32.8 | 32.6 | 32.5 | 33.3 | 34.2 | 26.7 | 33.7 |
| Supplemental | |||||||||||||||
| EBITDA | — | 481.6 | 440.1 | 282.7 | 220.0 | 141.7 | 278.3 | 267.8 | 327.3 | 325.6 | 471.9 | 432.0 | 279.9 | 83.1 | 161.2 |
| EBIT | 190.2 | 360.1 | 324.5 | 176.4 | 118.0 | 41.0 | 168.4 | 184.1 | 253.0 | 260.4 | 408.6 | 386.9 | 239.5 | 41.7 | 118.8 |
| Effective Tax Rate | 29.0% | — | — | 27.0% | 29.9% | 467.4% | 32.2% | 27.1% | 14.7% | 27.1% | 28.4% | 29.9% | 32.8% | 128.6% | 34.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.